vs

Side-by-side financial comparison of ASGN Inc (ASGN) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.

ASGN Inc is the larger business by last-quarter revenue ($970.0M vs $510.9M, roughly 1.9× Genius Sports Ltd). ASGN Inc runs the higher net margin — 0.6% vs -12.3%, a 12.9% gap on every dollar of revenue. Genius Sports Ltd produced more free cash flow last quarter ($69.6M vs $9.1M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs -3.2%).

ASGN Inc is a leading U.S.-headquartered professional services and workforce solutions provider. It specializes in supplying skilled talent and consulting services across high-growth segments including information technology, creative, digital, life sciences, and engineering, primarily serving enterprise clients across North America.

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

ASGN vs GENI — Head-to-Head

Bigger by revenue
ASGN
ASGN
1.9× larger
ASGN
$970.0M
$510.9M
GENI
Higher net margin
ASGN
ASGN
12.9% more per $
ASGN
0.6%
-12.3%
GENI
More free cash flow
GENI
GENI
$60.5M more FCF
GENI
$69.6M
$9.1M
ASGN
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
-3.2%
ASGN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ASGN
ASGN
GENI
GENI
Revenue
$970.0M
$510.9M
Net Profit
$5.5M
$-63.0M
Gross Margin
27.5%
25.2%
Operating Margin
2.9%
-11.5%
Net Margin
0.6%
-12.3%
Revenue YoY
-3.0%
Net Profit YoY
-73.7%
EPS (diluted)
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASGN
ASGN
GENI
GENI
Q1 26
$970.0M
Q4 25
$980.1M
$510.9M
Q3 25
$1.0B
$335.4M
Q2 25
$1.0B
$215.2M
Q1 25
$968.3M
$119.7M
Q4 24
$985.0M
$413.0M
Q3 24
$1.0B
$285.8M
Q2 24
$1.0B
$184.1M
Net Profit
ASGN
ASGN
GENI
GENI
Q1 26
$5.5M
Q4 25
$25.2M
$-63.0M
Q3 25
$38.1M
Q2 25
$29.3M
$-47.3M
Q1 25
$20.9M
$-25.5M
Q4 24
$42.4M
$-85.5M
Q3 24
$47.5M
$-47.1M
Q2 24
$47.2M
$-35.5M
Gross Margin
ASGN
ASGN
GENI
GENI
Q1 26
27.5%
Q4 25
28.9%
25.2%
Q3 25
29.4%
24.2%
Q2 25
28.7%
19.1%
Q1 25
28.4%
10.7%
Q4 24
29.0%
16.7%
Q3 24
29.1%
20.5%
Q2 24
29.1%
18.6%
Operating Margin
ASGN
ASGN
GENI
GENI
Q1 26
2.9%
Q4 25
5.7%
-11.5%
Q3 25
6.7%
-15.3%
Q2 25
5.8%
-21.0%
Q1 25
4.8%
-20.3%
Q4 24
7.5%
-18.0%
Q3 24
7.7%
-13.9%
Q2 24
7.8%
-16.8%
Net Margin
ASGN
ASGN
GENI
GENI
Q1 26
0.6%
Q4 25
2.6%
-12.3%
Q3 25
3.8%
Q2 25
2.9%
-22.0%
Q1 25
2.2%
-21.3%
Q4 24
4.3%
-20.7%
Q3 24
4.6%
-16.5%
Q2 24
4.6%
-19.3%
EPS (diluted)
ASGN
ASGN
GENI
GENI
Q1 26
$0.13
Q4 25
$0.58
Q3 25
$0.87
Q2 25
$0.67
Q1 25
$0.48
Q4 24
$0.94
Q3 24
$1.06
Q2 24
$1.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASGN
ASGN
GENI
GENI
Cash + ST InvestmentsLiquidity on hand
$143.6M
$280.6M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$1.8B
$724.5M
Total Assets
$4.0B
$1.1B
Debt / EquityLower = less leverage
0.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASGN
ASGN
GENI
GENI
Q1 26
$143.6M
Q4 25
$161.2M
$280.6M
Q3 25
$110.2M
Q2 25
$110.2M
Q1 25
$110.2M
Q4 24
$205.2M
$100.3M
Q3 24
$100.3M
Q2 24
$100.3M
Total Debt
ASGN
ASGN
GENI
GENI
Q1 26
$1.5B
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.3B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$1.0B
Stockholders' Equity
ASGN
ASGN
GENI
GENI
Q1 26
$1.8B
Q4 25
$1.8B
$724.5M
Q3 25
$1.8B
$572.4M
Q2 25
$1.8B
$572.4M
Q1 25
$1.8B
$572.4M
Q4 24
$1.8B
$573.0M
Q3 24
$1.8B
$573.0M
Q2 24
$1.8B
$573.0M
Total Assets
ASGN
ASGN
GENI
GENI
Q1 26
$4.0B
Q4 25
$3.7B
$1.1B
Q3 25
$3.7B
$792.3M
Q2 25
$3.7B
$792.3M
Q1 25
$3.7B
$792.3M
Q4 24
$3.4B
$775.7M
Q3 24
$3.4B
$775.7M
Q2 24
$3.5B
$775.7M
Debt / Equity
ASGN
ASGN
GENI
GENI
Q1 26
0.82×
Q4 25
0.65×
Q3 25
0.64×
Q2 25
0.66×
Q1 25
0.72×
Q4 24
0.58×
Q3 24
0.58×
Q2 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASGN
ASGN
GENI
GENI
Operating Cash FlowLast quarter
$81.9M
Free Cash FlowOCF − Capex
$9.1M
$69.6M
FCF MarginFCF / Revenue
0.9%
13.6%
Capex IntensityCapex / Revenue
1.0%
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$290.6M
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASGN
ASGN
GENI
GENI
Q1 26
Q4 25
$102.3M
$81.9M
Q3 25
$83.9M
$-4.8M
Q2 25
$124.9M
$-1.2M
Q1 25
$16.8M
$-14.6M
Q4 24
$100.2M
$14.9M
Q3 24
$135.8M
$-9.2M
Q2 24
$90.7M
Free Cash Flow
ASGN
ASGN
GENI
GENI
Q1 26
$9.1M
Q4 25
$93.7M
$69.6M
Q3 25
$72.0M
$-14.2M
Q2 25
$115.8M
$-5.8M
Q1 25
$6.6M
$-16.0M
Q4 24
$88.9M
$11.3M
Q3 24
$127.9M
$-11.6M
Q2 24
$85.4M
FCF Margin
ASGN
ASGN
GENI
GENI
Q1 26
0.9%
Q4 25
9.6%
13.6%
Q3 25
7.1%
-4.2%
Q2 25
11.3%
-2.7%
Q1 25
0.7%
-13.4%
Q4 24
9.0%
2.7%
Q3 24
12.4%
-4.1%
Q2 24
8.3%
Capex Intensity
ASGN
ASGN
GENI
GENI
Q1 26
1.0%
Q4 25
0.9%
2.4%
Q3 25
1.2%
2.8%
Q2 25
0.9%
2.1%
Q1 25
1.1%
1.2%
Q4 24
1.1%
0.9%
Q3 24
0.8%
0.9%
Q2 24
0.5%
Cash Conversion
ASGN
ASGN
GENI
GENI
Q1 26
Q4 25
4.06×
Q3 25
2.20×
Q2 25
4.26×
Q1 25
0.80×
Q4 24
2.36×
Q3 24
2.86×
Q2 24
1.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons